Illumina Inc ILMN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 12:36 PM EDT

119.30

-1.86 (-1.54%)

Volume

836,154

52 week range

89.00 - 232.23

Open119.20
Day High119.56
Day Low116.83
Prev Close121.16
52 Week High232.23
52 Week High Date04/19/23
52 Week Low89.00
52 Week Low Date11/10/23

Key Stats

Market Cap18.999B
Shares Out159.26M
10 Day Average Volume1.67M
Dividend-
Dividend Yield-
Beta1.21
YTD % Change-14.63

KEY STATS

Open119.20
Day High119.56
Day Low116.83
Prev Close121.16
52 Week High232.23
52 Week High Date04/19/23
52 Week Low89.00
52 Week Low Date11/10/23
Market Cap18.999B
Shares Out159.26M
10 Day Average Volume1.67M
Dividend-
Dividend Yield-
Beta1.21
YTD % Change-14.63

RATIOS/PROFITABILITY

EPS (TTM)-7.34
P/E (TTM)-16.25
Fwd P/E (NTM)139.37
EBITDA (TTM)359.00M
ROE (TTM)-18.79%
Revenue (TTM)4.504B
Gross Margin (TTM)60.95%
Net Margin (TTM)-25.75%
Debt To Equity (MRQ)25.92%

EVENTS

Earnings Date05/02/2024
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Illumina Inc

Jim Cramer goes Mad for March with a special Final Four version of Lightning RoundApril 5, 2024CNBC.com
Cramer's Lightning Round: Uber is a buyApril 5, 2024CNBC.com
Stocks making the biggest moves midday: Micron, Apple, Nvidia, Chewy and moreMarch 21, 2024CNBC.com

Content From Our Affiliates

Illumina $1B cash outlay for Grail divestment ‘better than fears,’ says EvercoreApril 12, 2024TipRanks
Illumina Gains Approval for GRAIL Divestiture PlansApril 12, 2024TipRanks
Illumina’s planned divestment of GRAIL approved by European CommissionApril 12, 2024TipRanks
Illumina (ILMN) Maintains Strong Guidance and Strategic Leadership AppointmentsApril 12, 2024TipRanks
Stephens Sticks to Their Buy Rating for Illumina (ILMN)April 11, 2024TipRanks

Profile

Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated...

Stephen Macmillan

Independent Non-Executive Chairman of the Board

Jacob Thaysen

Chief Executive Officer, Director

Joydeep Goswami

Chief Financial Officer

Steve Barnard

Chief Technology Officer

Carissa Rollins

Chief Information Officer

Address

5200 Illumina Way

San Diego, CA

92122-4616

United States

https://www.illumina.com

Top Peers

SYMBOL	LAST	CHG	%CHG
BNTX Biontech SE	87.15	-0.74	-0.84%
CRL Charles River Laboratories International Inc	233.31	-2.62	-1.11%
GMAB Genmab A/S	29.54	+0.02	+0.08%
INCY Incyte Corp	54.00	+0.57	+1.07%
ALNY Alnylam Pharmaceuticals Inc	147.51	-0.19	-0.13%